Ulf Holmbäck
Chief Scientific Officer Empros Pharma
Dr. Ulf Holmback is a distinguished scientist and pharmaceutical leader with a strong foundation in biomedical research and drug development. As the Chief Scientific Officer of Empros Pharma AB, he spearheads the company’s R&D strategy, driving innovation in therapeutics and drug delivery technologies to address unmet medical needs.
In addition to his industry leadership, Dr. Holmback maintains an active role in academia as an Associate Researcher at Uppsala University, bridging cutting-edge research with translational applications. His scientific journey includes a tenure as a Research Scholar at the University of Chicago, where he further honed his expertise in biomedical sciences.
Dr. Holmback holds a PhD in Biomedical Sciences from Uppsala University, where his research laid the groundwork for his deep understanding of drug mechanisms and formulation science. His multidisciplinary background spanning academia and industry, positions him as a key innovator in pharmaceutical development, with a focus on advancing novel therapies from concept to clinic.
Seminars
- Considering lifelong metabolic health for maintenance therapies beyond GLP-1s for better long term patient outcomes
- Identifying driving factors of meal-triggered dosing and behavioural reinforcement strategies to improve long-term outcomes by fostering metabolic health
- Exploring body composition and biomarkers as a gateway to improving life-long cardiometabolic health
- Understanding meal-triggered dosing that encourages conscious food choices to address weight rebound and aligns with lifelong metabolic health
- Revealing the benefits of safety-first approach to obesity therapies to avoid stringent monitoring, enabling broad long-term access for chromic management
- Unveiling EMP16’s modified release dual mechanism responsible for its proven safety and enhanced efficacy to provide a first-line cost-effective therapy
